Clinical Trial Update: PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy [Phase 2]

View source ↗

Summary

This document announces a Phase 2 clinical trial evaluating PULSAR in combination with fecal microbiota transplantation for advanced hepatocellular carcinoma th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)
• PULSAR

Snippet

Sponsor: Wang Xin | Conditions: Hepatocellular Carcinoma (HCC) | Phase 2 | Status: NOT_YET_RECRUITING